TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Takara Bio Inc. ( (JP:4974) ) has shared an update.
Takara Bio Inc. reported its consolidated financial results for the fiscal year ended March 31, 2025, showing a 3.5% increase in net sales compared to the previous year. Despite the increase in sales, the company experienced a decline in operating and ordinary profits by 24.6% and 23.9%, respectively. The company maintained its dividend payout, reflecting a stable return to shareholders, while forecasting a significant increase in net sales and profits for the next fiscal year.
The most recent analyst rating on (JP:4974) stock is a Hold with a Yen1000.00 price target. To see the full list of analyst forecasts on Takara Bio Inc. stock, see the JP:4974 Stock Forecast page.
More about Takara Bio Inc.
Takara Bio Inc. is a company listed on the Tokyo Stock Exchange, primarily involved in the biotechnology industry. The company focuses on developing and providing innovative products and services in the life sciences sector.
Average Trading Volume: 341,122
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen99.58B
For detailed information about 4974 stock, go to TipRanks’ Stock Analysis page.